GMAB
Genmab A/S
Revenue to net incomeFY2019
Key figures
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | DKK 5.4BFY2019 | — |
| Operating income | DKK 2.6BFY2019 | — |
| Net income | DKK 7.8BFY2024 | +29.4% |
| EPS | DKK 121.36FY2024 | +29.0% |
| Free cash flow | DKK 1.2BFY2019 | — |
Genmab A/S
| Metric | Latest | 5-year CAGR |
|---|---|---|
| Revenue | DKK 5.4BFY2019 | — |
| Operating income | DKK 2.6BFY2019 | — |
| Net income | DKK 7.8BFY2024 | +29.4% |
| EPS | DKK 121.36FY2024 | +29.0% |
| Free cash flow | DKK 1.2BFY2019 | — |